Category Archives: NuvaRing Risks

How a Blood Clot Becomes a Pulmonary Embolism

Posted in Adverse Events, NuvaRing, NuvaRing Risks, NuvaRing Safety, Risks and Side Effects, VTE | Leave a comment

CNN Interviews on NuvaRing

Marie Brenner Interview. Marie wrote an article in Vanity Fair in 2014

Posted in Adverse Events, Blood Clots, NuvaRing, NuvaRing Death, NuvaRing Risks, NuvaRing Safety, VTE, What Your Don't Doesn't Tell You | Tagged , , | Leave a comment

NuvaRing Risks to Your Health

Posted in Adverse Events, Blood Clots, DVT, NuvaRing, NuvaRing Death, NuvaRing Risks, NuvaRing Safety, Pulmonary Embolism, Stroke, Video Reports, VTE | Tagged , , , , | 1 Comment

WTVC NewsChannel 9 :: News – Top Stories – Birth Control Concerns

WTVC NewsChannel 9 :: News – Top Stories – Birth Control Concerns.

Posted in NuvaRing, NuvaRing Death, NuvaRing Risks, NuvaRing Safety | Leave a comment

Doctors Don’t Know What Women Want to Know About Birth Control

June 10, 2014:  NPR had an interesting article about what doctors don’t know about what women want to know about birth control.  You can read the entire article here, or go directly to the NPR site to also hear this … Continue reading

Posted in Adverse Events, Blood Clots, DVT, NuvaRing Death, NuvaRing Risks, NuvaRing Safety | Leave a comment

Listen | Wisconsin Public Radio

Listen | Wisconsin Public Radio.

Posted in Adverse Events, Blood Clots, FDA, NuvaRing, NuvaRing Risks, NuvaRing Safety | Tagged , , , | Leave a comment

The Continuous Low Dose that Isn’t a Continuous Low Dose

‘Continuous low dose’? Excerpt from Best Pills, Worst Pills April 2014 Newsletter: NUVARING continues to be marketed as delivering a “continuous low dose,” suggesting greater safety relative to other hormonal contraceptives, but there is little evidence actually supporting this implication.[35] … Continue reading

Posted in Blood Clots, DVT, FDA, NuvaRing, NuvaRing Death, NuvaRing Risks, NuvaRing risks and side effects, NuvaRing Safety, Stroke, What Your Don't Doesn't Tell You | Tagged , , , , , , , , | Leave a comment